![BEAM Alliance – Guidelines as to how antibacterial R&D could be revived and proposes specific support for SME-driven innovation in the AMR field.](https://www.amrindustryalliance.org/wp-content/uploads/2017/12/GettyImages-738786269-1080x675.jpg)
![BEAM Alliance – Guidelines as to how antibacterial R&D could be revived and proposes specific support for SME-driven innovation in the AMR field.](https://www.amrindustryalliance.org/wp-content/uploads/2017/12/GettyImages-738786269-1080x675.jpg)
![AiCuris Initiates Clinical Development of AIC499, a Novel Resistance-Breaking Antibiotic against a Broad Range of MDR Gram-Negative Bacteria](https://www.amrindustryalliance.org/wp-content/uploads/2017/12/GettyImages-525440711-1080x675.jpg)
AiCuris Initiates Clinical Development of AIC499, a Novel Resistance-Breaking Antibiotic against a Broad Range of MDR Gram-Negative Bacteria
![CARB-X Funding Award to Advance Development of LpxC Inhibitor Antibiotic to Fight Drug Resistant](https://www.amrindustryalliance.org/wp-content/uploads/2017/12/GettyImages-130404655-1080x675.jpg)
CARB-X Funding Award to Advance Development of LpxC Inhibitor Antibiotic to Fight Drug Resistant
![Merck & Co., Inc – Partnering with Local Hospitals Worldwide to Implement Antimicrobial Stewardship (AMS) Programs](https://www.amrindustryalliance.org/wp-content/uploads/2017/12/GettyImages-802473656-1080x675.jpg)
Merck & Co., Inc – Partnering with Local Hospitals Worldwide to Implement Antimicrobial Stewardship (AMS) Programs
![Leveraging global surveillance data to develop rapid diagnostics: MSD & OpGen’s Collaboration](https://www.amrindustryalliance.org/wp-content/uploads/2017/12/GettyImages-561094027-1080x675.jpg)